1. Home
  2. VSH vs IBRX Comparison

VSH vs IBRX Comparison

Compare VSH & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • IBRX
  • Stock Information
  • Founded
  • VSH 1962
  • IBRX 2014
  • Country
  • VSH United States
  • IBRX United States
  • Employees
  • VSH N/A
  • IBRX N/A
  • Industry
  • VSH Electrical Products
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSH Technology
  • IBRX Health Care
  • Exchange
  • VSH Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • VSH 2.3B
  • IBRX 2.3B
  • IPO Year
  • VSH N/A
  • IBRX N/A
  • Fundamental
  • Price
  • VSH $16.72
  • IBRX $2.26
  • Analyst Decision
  • VSH Hold
  • IBRX Strong Buy
  • Analyst Count
  • VSH 1
  • IBRX 6
  • Target Price
  • VSH $19.00
  • IBRX $9.83
  • AVG Volume (30 Days)
  • VSH 1.7M
  • IBRX 9.4M
  • Earning Date
  • VSH 11-05-2025
  • IBRX 11-10-2025
  • Dividend Yield
  • VSH 2.38%
  • IBRX N/A
  • EPS Growth
  • VSH N/A
  • IBRX N/A
  • EPS
  • VSH N/A
  • IBRX N/A
  • Revenue
  • VSH $2,927,555,000.00
  • IBRX $56,600,000.00
  • Revenue This Year
  • VSH $4.58
  • IBRX $629.94
  • Revenue Next Year
  • VSH $7.19
  • IBRX $109.91
  • P/E Ratio
  • VSH N/A
  • IBRX N/A
  • Revenue Growth
  • VSH N/A
  • IBRX 4227.22
  • 52 Week Low
  • VSH $10.35
  • IBRX $1.83
  • 52 Week High
  • VSH $20.15
  • IBRX $5.88
  • Technical
  • Relative Strength Index (RSI)
  • VSH 52.31
  • IBRX 39.09
  • Support Level
  • VSH $16.64
  • IBRX $2.30
  • Resistance Level
  • VSH $17.79
  • IBRX $2.67
  • Average True Range (ATR)
  • VSH 0.63
  • IBRX 0.12
  • MACD
  • VSH -0.03
  • IBRX -0.02
  • Stochastic Oscillator
  • VSH 38.57
  • IBRX 1.19

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: